Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Research Article

Magnetic Resonance Imaging Assessment of Radial Scars/complex Sclerosing Lesions of the Breast

Author(s): Xavier Bargallo*, Belen Ubeda, Sergi Ganau, Blanca Gonzalez, Miguel Macedo, Inma Alonso, Gabriela Oses, Maria Vidal and Gorane Santamaria

Volume 18, Issue 2, 2022

Published on: 31 December, 2020

Article ID: e040122189676 Pages: 7

DOI: 10.2174/1573405616666201231095918

Abstract

Purpose: To describe the magnetic resonance characteristics of radial scars/complex sclerosing lesions (RS/CSL) of the breast using the current BI-RADS lexicon. To investigate the value of diffusion weighted imaging to predict malignancy.

Patients and Methods: From 2010 to 2017, we have found 25 women with architectural distortion at mammography who underwent surgical resection with a final hystopathologic report of RS/CSL. For the description of MRI findings, we adhered to BI-RADS classification (5th edition).

Results: The final pathological diagnosis was: “pure” RS/CSL in 7 cases (28%), RS/CSL with associated high risk lesions in 12 (48%) and 6 cases (24%) were associated with malignancy.

Magnetic resonance findings: four of 25 negative or focus. Five of 25 mass enhancement: irregular, non circumscribed spiculated mass with heterogeneous or rim enhancement and most with type II curves. Sixteen of 25 non mass enhancement: focal or linear distribution and heterogeneous internal enhancement most with type I curves. Six of 25 had cancer associated with the complex sclerosing lesion. All six showed non-mass enhancement.

Two cases with invasive breast carcinoma had ADC values under 1.15 x10−3 mm/s while most of the rest had the values above.

Conclusion: Most RS/CSL showed enhancement at MR. The predominant pattern was a non-mass, focal, heterogeneous internal enhancement with type 1 curves. All cases with associated cancer showed non mass enhancement. Invasive breast cancers had ADC values < 1.15 10-3 s/mm2.

Keywords: Radial scar, complex sclerosing lesion, breast cancer, magnetic resonance imaging, elastosis, ADC.

Graphical Abstract

[1]
A.T. Page DL. Radial scars and complex sclerosing lesions.Diagnostic histopathology of the breast. Edinburgh: Churchill Livingstone 1987; pp. 89-103.
[2]
Azavedo E, Svane G. Radial scars detected mammographically in a breast cancer screening programme. Eur J Radiol 1992; 15(1): 18-21.
[http://dx.doi.org/10.1016/0720-048X(92)90196-G] [PMID: 1396782]
[3]
Osborn G, Wilton F, Stevens G, Vaughan-Williams E, Gower-Thomas K. A review of needle core biopsy diagnosed radial scars in the Welsh Breast Screening Programme. Ann R Coll Surg Engl 2011; 93(2): 123-6.
[http://dx.doi.org/10.1308/003588411X12851639107953] [PMID: 21073820]
[4]
Nassar A, Conners AL, Celik B, Jenkins SM, Smith CY, Hieken TJ. Radial scar/complex sclerosing lesions: a clinicopathologic correlation study from a single institution. Ann Diagn Pathol 2015; 19(1): 24-8.
[http://dx.doi.org/10.1016/j.anndiagpath.2014.12.003] [PMID: 25578683]
[5]
Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Engl J Med 1999; 340(6): 430-6.
[http://dx.doi.org/10.1056/NEJM199902113400604] [PMID: 9971867]
[6]
Sanders ME, Page DL, Simpson JF, Schuyler PA, Dale Plummer W, Dupont WD. Interdependence of radial scar and proliferative disease with respect to invasive breast carcinoma risk in patients with benign breast biopsies. Cancer 2006; 106(7): 1453-61.
[http://dx.doi.org/10.1002/cncr.21730] [PMID: 16502407]
[7]
Berg JC, Visscher DW, Vierkant RA, et al. Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat 2008; 108(2): 167-74.
[http://dx.doi.org/10.1007/s10549-007-9605-9] [PMID: 18297395]
[8]
Collins LC, Aroner SA, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM. Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses’ Health Studies. Cancer 2016; 122(4): 515-20.
[http://dx.doi.org/10.1002/cncr.29775] [PMID: 26565738]
[9]
Manfrin E, Remo A, Falsirollo F, Reghellin D, Bonetti F. Risk of neoplastic transformation in asymptomatic radial scar. Analysis of 117 cases. Breast Cancer Res Treat 2008; 107(3): 371-7.
[http://dx.doi.org/10.1007/s10549-007-9569-9] [PMID: 17457669]
[10]
B.E. Sickles E, D’Orsi C, Bassett L, Appleton C, Berg W. ACR BI-RADS ® Atlas Breast Imaging Reporting and Data System. 5 edition. Reston (VA) 2013.
[11]
Pediconi F, Occhiato R, Venditti F, et al. Radial scars of the breast: contrast-enhanced magnetic resonance mammography appearance. Breast J 2005; 11(1): 23-8.
[http://dx.doi.org/10.1111/j.1075-122X.2005.21530.x] [PMID: 15647074]
[12]
Perfetto F, Fiorentino F, Urbano F, Silecchia R. Adjunctive diagnostic value of MRI in the breast radial scar. Radiol Med (Torino) 2009; 114(5): 757-70.
[http://dx.doi.org/10.1007/s11547-009-0405-7] [PMID: 19484584]
[13]
Linda A, Zuiani C, Londero V, Cedolini C, Girometti R, Bazzocchi M. Magnetic resonance imaging of radial sclerosing lesions (radial scars) of the breast. Eur J Radiol 2012; 81(11): 3201-7.
[http://dx.doi.org/10.1016/j.ejrad.2012.01.038] [PMID: 22386132]
[14]
Ha SM, Cha JH, Shin HJ, et al. Radial scars/complex sclerosing lesions of the breast: radiologic and clinicopathologic correlation. BMC Med Imaging 2018; 18(1): 39.
[http://dx.doi.org/10.1186/s12880-018-0279-z] [PMID: 30390667]
[15]
Bogner W, Gruber S, Pinker K, et al. Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis? Radiology 2009; 253(2): 341-51.
[http://dx.doi.org/10.1148/radiol.2532081718] [PMID: 19703869]
[16]
Marini C, Iacconi C, Giannelli M, Cilotti A, Moretti M, Bartolozzi C. Quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesion. Eur Radiol 2007; 17(10): 2646-55.
[http://dx.doi.org/10.1007/s00330-007-0621-2] [PMID: 17356840]
[17]
Partridge SC, Mullins CD, Kurland BF, et al. ADC values for discriminating benign and malignant breast MRI lesions: Effects of lesion type and size. AJR Am J Roentgenol 2010; 194(6): 1664-73.
[http://dx.doi.org/10.2214/AJR.09.3534] [PMID: 20489111]
[18]
Linda A, Zuiani C, Furlan A, et al. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI? AJR Am J Roentgenol 2012; 198(2): 272-80.
[http://dx.doi.org/10.2214/AJR.11.7040] [PMID: 22268168]
[19]
Farshid G, Buckley E. Meta-analysis of upgrade rates in 3163 radial scars excised after needle core biopsy diagnosis. Breast Cancer Res Treat 2019; 174(1): 165-77.
[http://dx.doi.org/10.1007/s10549-018-5040-3] [PMID: 30460464]
[20]
Bacci J, MacGrogan G, Alran L, Labrot-Hurtevent G. Management of radial scars/complex sclerosing lesions of the breast diagnosed on vacuum-assisted large-core biopsy: is surgery always necessary? Histopathology 2019; 75(6): 900-15.
[http://dx.doi.org/10.1111/his.13950] [PMID: 31286532]
[21]
Rakha E, Beca F, D’Andrea M, et al. Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study. J Clin Pathol 2019; 72(12): 800-4.
[http://dx.doi.org/10.1136/jclinpath-2019-205764] [PMID: 31350292]
[22]
Pinder SE, Shaaban A, Deb R, et al. NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions). Clin Radiol 2018; 73(8): 682-92.
[http://dx.doi.org/10.1016/j.crad.2018.04.004] [PMID: 29773220]
[23]
Rageth CJ, O’Flynn EAM, Pinker K, et al. Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 2019; 174(2): 279-96.
[http://dx.doi.org/10.1007/s10549-018-05071-1] [PMID: 30506111]

© 2024 Bentham Science Publishers | Privacy Policy